During the past decade, NoesisPharma, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NoesisPharma, LLC" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NoesisPharma, LLC" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "NoesisPharma, LLC" are "Depressive Disorder, Major" (6 trials), "Major Depressive Disorder" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "PTSD" (2 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "NoesisPharma, LLC" in a lesser frequency.

Most popular intervention types in "NoesisPharma, LLC" are "Drug" (22 trials), "Other" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Rapastinel" (4 trials), "AVP-786" (2 trials), "TNX-102 SL" (2 trials) and "Assay-guided treatment (AGT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NoesisPharma, LLC" are 23 trials for "All" genders.

Currently, there are NaN active trials in "NoesisPharma, LLC". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in NoesisPharma, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NoesisPharma, LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".